CME Mission Statement
ASCRS’ continuing medical education mission is to improve the competence of ophthalmologists/anterior segment surgeons by offering an avenue for the presentation and discussion of innovative techniques and technologies and fostering an open environment where current practices are presented and questions and improvements in patient care are continually sought.
Accreditation Statement
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The American Society of Cataract and Refractive Surgery designates this educational activity is designated for a maximum 5.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Attendees registered as exhibitors are not eligible for CME credits.
All CME activities approved for AMA PRA Category 1 Credit™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.
Target Audience
This educational activity has been designed for anterior segment specialists, comprehensive ophthalmologists, residents, fellows, and practice implementers.
Educational Objectives
Upon completion participants should be able to:
- Compare refractive IOLs and provide practical pearls and pitfalls for implanting different refractive IOLs.
- Examine refractive lens exchange and discuss selecting patients and determining the best individual refractive IOL choice.
- Outline how to establish or enhance a refractive IOL practice and how to improve communication efficacy.
- Employ tips for office and organization workflow that are specific to the evaluation and counseling of a refractive IOL patient.
- Discuss management of an unhappy refractive IOL patient and refractive or surgical complications.
- Recognize when to consider a refractive enhancement.
- Compare and contrast refractive enhancement options.
- Employ strategies for lens exchange techniques and/or how to enhance a lens.
Scientific Integrity and Disclosure of Financial Interest
It is the American Society of Cataract and Refractive Surgery’s policy that all continuing medical education is fair and balanced. Additionally, the clinical content of accredited educational activities must be evidence-based, support safe and effective patient care, and be free of commercial bias. All individuals in a position to control content of CME activities must disclose any and all financial relationships for the past 24 months. ASCRS has mechanisms in place to identify and mitigate all conflicts of interest prior to an educational activity being delivered to learners and will disclose all relevant relationships (and absence of) to learners.
Notice About Off-Label Use Presentations
The ASCRS Annual Meeting may include presentations on drugs or devices, or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wished to use in clinical practice.
ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented.
CME Credit Questions
Attendees will receive a post-event survey and CME credit claim on Sunday, October 5,via email. Please contact [email protected] with any questions on credit claims.
Financial Relationship Index
Relevant Financial Interest Index
As a provider accredited by the Accreditation Council for Continuing Medical Education, ASCRS must ensure balance, independence, objectivity, and scientific rigor in all its individually or jointly provided activities.
All individuals participating in an activity designated for CME credit must disclose any financial relationship with an ineligible company that produces, markets, sells, resells, or distributes ophthalmic products/devices/drugs or services used on or by patients that are discussed in an educational presentation or lack thereof. Financial relationships can include such things as grants or research support, consultant, stockholder, member of speaker’s bureau, et.
The intent of this disclosure is not to disqualify anyone from participating, but to provide the program committee with information so they can design and implement a balanced, independent, and scientific educational activity. The Financial Relationship Index provides information to attendees, so they can make their own judgement regarding the interest or relationship and the materials presented. A complete listing of relations disclosed, and their corresponding codes are below.
| Category | Code | Description |
|---|---|---|
| EO | ||
| Researcher | R | |
| Consultant | C | I am an advisor to an Ineligible Company. |
| Advisor | A | I am an advisor to an Ineligible Company, Including, for example, advisory boards. |
| Speaker | S | |
| Independent contractor (including contracted research) |
IC | |
| Royalties or patent beneficiary |
RP | |
| Individual stocks from a Privately-held company |
SP | |
| Individual stocks from a publicly traded organization |
SU | |
| Stock Options | SO | |
| * Ineligible companies are ineligible to be accredited by the Accreditation Council for Continuing Medical Education (ACCME), and include these types of organizations: (1) biomedical startups that have begun the regulatory approval process, (2) compounding pharmacies that manufacture proprietary compounds, (3) device manufacturers or distributors; (4) diagnostic labs that sell proprietary products; (5) growers, distributors, manufacturers or sellers of medical foods and dietary supplements; (6) manufacturers of health-related wearable products; (7) pharmaceutical companies or distributors; pharmacy benefit managers; and (8) reagent manufacturers or sellers. | ||
Patti Barkey, COE, is a speaker for Bausch & Lomb.
Deborah Davis, COE, has no relevant financial relationships.
Nicole Fram, MD,is an advisor for BVI and LayerBio. She is a consultant for Abbvie, Alcon, Johnson & Johnson, RxSight, and Zeiss. She is a researcher for Zeiss. She is also a speaker for Alcon, Johnson & Johnson, MST, RxSight, and Zeiss.
Carrie Jacobs, COE, is a consultant for Alcon and RxSight.
Matt Jensen is a consultant for RxSight.
Jaime Johannesen has no relevant financial relationships.
Mary Pat Johnson has no relevant financial relationships.
Jennifer Loh, MD, is an advisor for Abbvie, Alcon, Bausch & Lomb, BioTissue, BVI, Johnson & Johnson, Lensar, and Zeiss. She is a speaker for Alcon and Bausch & Lomb.
Vance Thompson, MD, is a consultant and researcher for Alcon, Bausch & Lomb, Johnson & Johnson, Rayner, RxSight, and STAAR Surgical. He also consults and has individual stocks from a publicly traded organization with Lensar. He has stock options with Rayner.
Richard Tipperman, MD, is a consultant for Alcon and BVI. He is also a speaker for Alcon.
William Trattler, MD, is an advisor for Alcon and Bausch & Lomb. He is a consultant for Alcon, Bausch & Lomb, BioTissue, Johnson & Johnson, Lensar, STAAR Surgical, and Zeiss. He is a researcher for Bausch & Lomb. He is also a speaker for Alcon, Bausch & Lomb, and Lensar.
William Wiley, MD, is an advisor and researcher for Alcon, Bausch & Lomb, and Johnson & Johnson. He is a consultant for Alcon and Bausch & Lomb. He is a speaker for Alcon and Johnson & Johnson. He has individual stocks from a publicly traded organization with RxSight.
Dagny Zhu, MD, is a consultant for Alcon, Bausch & Lomb, BVI, Johnson & Johnson, Lensar, and STAAR Surgical. She is an advisor for Alcon, Bausch & Lomb, Johnson & Johnson, and Lensar. She is a speaker for Alcon and Johnson & Johnson. She is also a researcher for Alcon and Lensar.
Crista Parker, Nicole Hanson-Emerson, Kim Managan, and Lindsay Kunz, ASCRS Staff, have no relevant financial relationships.
All relevant financial relationships for these individuals have been mitigated.
